Zobrazeno 1 - 10
of 124
pro vyhledávání: '"Moon HE"'
Autor:
Zhicheng XU, Mengqi Moon HE
Publikováno v:
Landscape Architecture Frontiers; Jun2023, Vol. 11 Issue 3, p132-138, 7p
Publikováno v:
Nuclear Engineering and Technology, Vol 56, Iss 7, Pp 2659-2665 (2024)
This study proposes an algorithm that combines a Kalman Filter method with effective decay constant correction to improve the accuracy of predicting radiation dose rate distribution during emergencies. The algorithm addresses the limitations of relyi
Externí odkaz:
https://doaj.org/article/c4cee5c47e72423a8ac84eb7e5d2f3d0
Autor:
Moon-He Chai, Hye-In Sim
Publikováno v:
Korean Association of Criminal Psychology. 15:141-156
Autor:
Hoang Duc Le, Tuyet Ngan Thai, Jae-Kyeom Kim, Hye-Soon Song, Moon Her, Xuan Thach Tran, Ji-Ye Kim, Hye-Ryoung Kim
Publikováno v:
Viruses, Vol 16, Iss 4, p 515 (2024)
Infectious bronchitis virus (IBV) causes a highly contagious respiratory disease in chickens, leading to significant economic losses in the poultry industry worldwide. IBV exhibits a high mutation rate, resulting in the continuous emergence of new va
Externí odkaz:
https://doaj.org/article/bba597d0c1fa4755bf0d00614b47cf3c
Moving reactor model for the MULTID components of the system thermal-hydraulic analysis code MARS-KS
Publikováno v:
Nuclear Engineering and Technology, Vol 54, Iss 11, Pp 4373-4391 (2022)
Marine reactor systems experience platform movement, and therefore, the system thermal-hydraulic analysis code needs to reflect the motion effect on the fluid to evaluate reactor safety. A moving reactor model for MARS-KS was developed to simulate th
Externí odkaz:
https://doaj.org/article/025a4d2f66a949c8b2a577c243a2626c
Autor:
Moon Hee Lee, Kyung Sung, David Beebe, Wei Huang, Dan Shapiro, Shigeki Miyamoto, E. Jason Abel
Publikováno v:
Oncogenesis, Vol 11, Iss 1, Pp 1-9 (2022)
Abstract While an important role for the SUMO protease SENP1 is recognized in multiple solid cancers, its role in renal cell carcinoma (RCC) pathogenesis, particularly the most dominant subtype, clear cell RCC (ccRCC), is poorly understood. Here we s
Externí odkaz:
https://doaj.org/article/5ee96a81e3a44b89bac3dc2f5661c0ee
Autor:
Chae Hong Rhee, Hye-sook Lee, Hyeong-jun Yun, Ga-Hee Lee, Su-Jeong Kim, Sok Song, Myoung-Heon Lee, Moon Her, Wooseog Jeong
Publikováno v:
Frontiers in Chemistry, Vol 11 (2023)
Introduction: The product labels of veterinary disinfectants specify their expiration dates to prevent the use of outdated products, as these may result in disinfection and biosecurity failures during outbreak situations. However, a clear standard fo
Externí odkaz:
https://doaj.org/article/f51803d21331452b9a8b4225381a2df4
Autor:
Moon Hee Lee, Essi Laajala, Anna Kreutzman, Petrus Järvinen, Harry Nísen, Tuomas Mirtti, Maija Hollmén, Satu Mustjoki
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Renal cell carcinoma (RCC) accounts for 90% of all renal cancers and is considered highly immunogenic. Although many studies have reported the circulating peripheral cytokine profiles, the signatures between the tumor tissue and matching hea
Externí odkaz:
https://doaj.org/article/4a93417b438340b78c35c73444c21f35
Autor:
Young Hoon Park, Dae-Young Kim, Yeung-Chul Mun, Eun Kyung Cho, Jae Hoon Lee, Deog-Yeon Jo, Inho Kim, Sung-Soo Yoon, Seon Yang Park, Byoungkook Kim, Soo-Mee Bang, Hawk Kim, Young Joo Min, Jae Hoo Park, Jong Jin Seo, Hyung Nam Moon, Moon Hee Lee, Chul Soo Kim, Won Sik Lee, So Young Chong, Doyeun Oh, Dae Young Zang, Kyung Hee Lee, Myung Soo Hyun, Heung Sik Kim, Sung-Hyun Kim, Hyukchan Kwon, Hyo Jin Kim, Kyung Tae Park, Sung Hwa Bae, Hun Mo Ryoo, Jung Hye Choi, Myung-Ju Ahn, Hwi-Joong Yoon, Sung-Hyun Nam, Bong-Seog Kim, Chu-Myong Seong
Publikováno v:
The Korean Journal of Internal Medicine, Vol 37, Iss 4, Pp 841-850 (2022)
Background/Aims We evaluated the feasibility and long-term efficacy of the combination of cytarabine, idarubicin, and all-trans retinoic acid (ATRA) for treating patients with newly diagnosed acute promyelocytic leukemia (APL). Methods We included 87
Externí odkaz:
https://doaj.org/article/8bb1289c131e4f98880b290e603ef77a
Autor:
Jani Huuhtanen, Henna Kasanen, Katriina Peltola, Tapio Lönnberg, Virpi Glumoff, Oscar Brück, Olli Dufva, Karita Peltonen, Johanna Vikkula, Emmi Jokinen, Mette Ilander, Moon Hee Lee, Siru Mäkelä, Marta Nyakas, Bin Li, Micaela Hernberg, Petri Bono, Harri Lähdesmäki, Anna Kreutzman, Satu Mustjoki
Publikováno v:
The Journal of Clinical Investigation, Vol 133, Iss 6 (2023)
Background Relatlimab plus nivolumab (anti–lymphocyte-activation gene 3 plus anti–programmed death 1 [anti–LAG-3+anti–PD-1]) has been approved by the FDA as a first-line therapy for stage III/IV melanoma, but its detailed effect on the immune
Externí odkaz:
https://doaj.org/article/45e8a21ae8814471ba60e41684de20f1